miRNAs in non-alcoholic fatty liver disease

被引：0
作者：
Zhen He
Cheng Hu
Weiping Jia
机构：
[1] Shanghai Jiao Tong University Affiliated Sixth People’s Hospital,Shanghai Diabetes Institute, Shanghai Key Laboratory of Diabetes Mellitus, Shanghai Clinical Center for Diabetes
来源：
Frontiers of Medicine | 2016年 / 10卷
关键词：
nonalcoholic fatty liver disease; nonalcoholic steatohepatitis; hepatocellular carcinoma; miRNA;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
Non-alcoholic fatty liver disease (NAFLD) is a major cause of liver cirrhosis and hepatocellular carcinoma and is a considerable threat to public health. miRNAs are important post-transcriptional regulators of gene expression, and the dysregulation of miRNAs is involved in various biological processes in the liver, including lipid homeostasis, inflammation, apoptosis, and cell proliferation. Recently, a number of studies have described the association between miRNAs and NAFLD progression and have shown that circulating miRNAs reflect histological changes in the liver. Therefore, circulating miRNAs have potential use for the evaluation of NAFLD severity. In this review, we discuss the involvement of miRNAs in NAFLD pathogenesis and the key role of miRNAs in the screening, diagnosis, and staging of NAFLD.
引用
收藏
页码：389 / 396
页数：7
相关论文
共 385 条
[11]  
Van Thiel DH(2016)Role of microRNAs in NAFLD/NASH Dig Dis Sci 61 1314-2897
[12]  
Yki-Järvinen H(2016)MicroRNA expression analysis in high fat diet-induced NAFLD-NASH-HCC progression: study on C57BL/6J mice BMC Cancer 16 3-63
[13]  
Than NN(2012)MicroRNA-122 plays a critical role in liver homeostasis and hepatocarcinogenesis J Clin Invest 122 2884-98
[14]  
Newsome PN(2011)The role of microRNAs in cholesterol efflux and hepatic lipid metabolism Annu Rev Nutr 31 49-541
[15]  
Ul Hussain M(2006)miR-122 regulation of lipid metabolism revealed by in vivo antisense targeting Cell Metab 3 87-1131
[16]  
Wang XW(2015)microRNA-122 regulates hypoxia-inducible factor-1 and vimentin in hepatocytes and correlates with fibrosis in diet-induced steatohepatitis Liver Int 35 532-72
[17]  
Heegaard NH(2002)SREBPs: activators of the complete program of cholesterol and fatty acid synthesis in the liver J Clin Invest 109 1125-1569
[18]  
Orum H(2012)SREBPs: metabolic integrators in physiology and metabolism Trends Endocrinol Metab 23 65-9237
[19]  
Pirola CJ(2010)MicroRNA-33 and the SREBP host genes cooperate to control cholesterol homeostasis Science 328 1566-407
[20]  
Fernández Gianotti T(2011)miR-33a/b contribute to the regulation of fatty acid metabolism and insulin signaling Proc Natl Acad Sci USA 108 9232-1141
12345678910